Clinical Trial Diversity, Equity, and Inclusion: Roadmap of the Cardiothoracic Surgical Trials Network

被引:0
|
作者
Lala, Anuradha [1 ]
Louis, Clauden
Vervoort, Dominique [3 ]
Iribarne, Alexander [4 ]
Rao, Aarti
Taddei-Peters, Wendy C. [5 ]
Raymond, Samantha
Bagiella, Emilia
O'Gara, Patrick [6 ]
Thourani, Vinod H. [7 ]
Badhwar, Vinay [8 ]
Chikwe, Joanna [9 ]
Jessup, Mariell [10 ]
Jeffries, Neal [11 ]
Moskowitz, Alan J.
Gelijns, Annetine C. [2 ]
Rodriguez, Carlos J. [12 ]
机构
[1] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Med Cardiol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Populat Hlth Sci & Policy, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[4] Staten Isl Univ Hosp, Northwell Hlth, Dept Cardiothorac Surg, Staten Isl, NY USA
[5] Natl Heart Lung & Blood Inst, Div Cardiovasc Sci, NIH, Bethesda, MD USA
[6] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USA
[7] Piedmont Heart Inst, Marcus Valve Ctr, Dept Cardiovasc Surg, Atlanta, GA USA
[8] West Virginia Univ, Dept Cardiovasc & Thorac Surg, Morgantown, WV USA
[9] CEDARS SINAI MED CTR, DEPT CARDIAC SURG, LOS ANGELES, CA USA
[10] Amer Heart Assoc, Dallas, TX USA
[11] NHLBI, Off Biostat Res, NIH, Bethesda, MD USA
[12] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med Cardiol Epidemiol & Populat Hlth, Bronx, NY USA
来源
ANNALS OF THORACIC SURGERY | 2024年 / 118卷 / 06期
基金
加拿大健康研究院;
关键词
VALVULAR HEART-DISEASE; UNDER-REPRESENTATION; ATRIAL-FIBRILLATION; AFRICAN-AMERICANS; RACE; OUTCOMES; FAILURE; SURGERY; REPLACEMENT; MODERATE;
D O I
10.1016/j.athoracsur.2024.03.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND There is a recognized lack of diversity among patients enrolled in cardiovascular interventional and surgical trials. Diverse patient representation in clinical trials is necessary to enhance generalizability of findings, which may lead to better outcomes across broader populations. The Cardiothoracic Surgical Trials Network (CTSN) recently developed a plan of action to increase diversity among participating investigators and trial participants and is the focus of this review. METHODS A review of literature and enrollment data from CTSN trials was conducted. RESULTS CTSN completed more than a dozen major clinical trials (2008-2022), enrolling >4000 patients, of whom 30% were women, 11% were non-White, and 5.6% were Hispanic. CTSN also completed trials of hospitalized patients with coronavirus disease 2019, wherein enrollment was more diverse, with 42% women, and 58% were Asian, Black, Hispanic, or from another underrepresented racial group. The discrepancy in diversity of enrollment between cardiac surgery trials and coronavirus disease trials highlights the need for a more comprehensive understanding of (1) the prevalence of underlying disease requiring cardiac interventions across broad populations, (2) differences in access to care and referral for cardiac surgery, and (3) barriers to enrollment in cardiac surgery trials. CONCLUSIONS Committed to diversity, CTSN's multifaceted action plan includes developing site-specific enrollment targets, collecting social determinants of health data, understanding reasons for nonparticipation, recruiting sites that serve diverse populations, emphasizing greater diversity among clinical trial teams, and implicit bias training. The CTSN will prospectively assess how these interventions influence enrollment as we work to ensure trial participants are more representative of the communities we serve. (Ann Thorac Surg 2024;118:1327-37) (c) 2024 by The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1327 / 1337
页数:11
相关论文
共 50 条
  • [41] Increasing diversity and inclusion in nephrology clinical trials
    Bessie A. Young
    Sylvia E. Rosas
    Nature Reviews Nephrology, 2023, 19 : 627 - 628
  • [42] Diversity, Equity, and Inclusion in Urolithiasis Clinical Trials: Representative Enrollment by Race, Ethnicity, and Sex Editorial Commentary
    Moussa, Ayman S.
    UROLOGY PRACTICE, 2024, 11 (04) : 691 - 691
  • [43] Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network
    Smith, Peter K.
    Michler, Robert E.
    Woo, Y. Joseph
    Alexander, John H.
    Puskas, John D.
    Parides, Michael K.
    Hahn, Rebecca T.
    Williams, Judson B.
    Dent, John M.
    Ferguson, T. Bruce, Jr.
    Moquete, Ellen
    Rose, Eric A.
    Page, Pierre
    Jeffries, Neal O.
    O'Gara, Patrick T.
    Ascheim, Deborah D.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 143 (01): : 111 - U175
  • [44] Cost-Effectiveness of Repair versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network
    Ferket, Bart S.
    Ailawadi, Gorav
    Gelijns, Annetine
    Acker, Michael A.
    Hohmann, Samuel F.
    Chang, Helena
    Bouchard, Denis
    Meltzer, David
    Michler, Robert E.
    Moquete, Ellen
    Voisine, Pierre
    Mullen, John C.
    Mack, Michael
    Gillinov, A. M.
    Thourani, Vinod
    Miller, Marissa A.
    Gammie, James
    Parides, Michael
    Bagiella, Emilia
    Smith, Robert L.
    Smith, Peter K.
    Hung, Judy W.
    Gupta, Lopa
    Rose, Eric A.
    O'Gara, Patrick
    Moskowitz, Alan
    CIRCULATION, 2016, 134
  • [45] Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
    Mayer-Hamblett, Nicole
    Clancy, John Paul
    Jain, Raksha
    Donaldson, Scott H.
    Fajac, Isabelle
    Goss, Christopher H.
    Polineni, Deepika
    Ratjen, Felix
    Quon, Bradley S.
    Zemanick, Edith
    Bell, Scott C.
    Davies, Jane C.
    Jain, Manu
    Konstan, Michael W.
    Kerper, Natanya R.
    LaRosa, Tre
    Mall, Marcus A.
    McKone, Edward
    Pearson, Kelsie
    Pilewski, Joseph M.
    Quittell, Lynne
    Rayment, Jonathan H.
    Rowe, Steven M.
    Taylor-Cousar, Jennifer L.
    Retsch-Bogart, George
    Downey, Damian
    LANCET RESPIRATORY MEDICINE, 2023, 11 (10): : 932 - 944
  • [46] The Cardiothoracic Surgery Network: Randomized clinical trials in the operating room
    Gardner, Timothy J.
    O'Gara, Patrick T.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (04): : 830 - 834
  • [47] Roadmap for the European Network of Gynaecological Trial Groups (ENGOT) Trials
    Vergote, Ignace
    Elser, Gabriele
    Votan, Benedicte
    Farrelly, Laura
    De Roover, Joke
    Bryce, Jane
    du Bois, Andreas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (07) : 1339 - 1343
  • [48] A Commitment to Diversity, Equity, and Inclusion at Global Surgical Education - Journal of the Association for Surgical Education
    M. Libby Weaver
    Gurjit Sandhu
    Global Surgical Education - Journal of the Association for Surgical Education, 2 (1):
  • [49] Diversity, Equity, and Inclusion: A strategic priority for the American Pediatric Surgical Association
    Morrison, Zachary D.
    Reyes-Ferral, Cynthia
    Mansfield, Sara A.
    Alemayehu, Hanna
    Bowen-Jallow, Kanika
    Tran, Sifrance
    Santos, Mary Catherine
    Bischoff, Andrea
    Perez, Numa
    Lopez, Monica E.
    Langham, Max R., Jr.
    Newman, Erika A.
    JOURNAL OF PEDIATRIC SURGERY, 2021, 56 (04) : 641 - 647
  • [50] Diversity, equity, and inclusion in presidential leadership of academic medical and surgical societies
    Kearse, LaDonna E.
    Goll, Cassidi K.
    Jensen, Rachel M.
    Wise, Brett J.
    Witt, Anna K.
    Huemer, Kayla
    Korndorffer, James R., Jr.
    Pugh, Carla M.
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (04): : 1028 - 1031